Back to search

Article

p53 as a Convergent Genetic Modifier in Chronic Kidney Disease: Unifying Genetic Risk and Defining Renal Modulatory Drugs

2026-04-19

Abstract excerpt

<title>Abstract</title> <p>Background Chronic kidney disease (CKD) affects more than 850 million individuals worldwide. Secondary genetic risk modifiers including APOL1, MYH9, GPX1, SOD2, ACE, AGT, AQP11, MBL2, PLA2R1, ABCG8, and MBOAT7 operate through mechanistically distinct pathways yet converge on identical tubulointerstitial fibrosis and end-stage kidney disease (ESKD). No unifying molecular framework expla...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
298ab57d-e22e-50ab-b2cb-aa1f2edbb2c5
DOI
10.21203/rs.3.rs-9434477/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
p53 as a Convergent Genetic Modifier in Chronic Kidney Disease: Unifying Genetic Risk and Defining Renal Modulatory DrugsDOI 10.21203/rs.3.rs-9434477/v1
Select a neighboring publication to make it the new centre.